
Investors should prioritize the Health & Wellness sector by shifting away from "Big Food" stocks, which face increasing regulatory risks and consumer backlash against ultra-processed ingredients and artificial dyes. Look for growth opportunities in subscription-based supplement models like North Performance, which capitalize on "supplement fatigue" by consolidating high-end nutrients like Creatine, NMN, and Amino Acids into single-serve daily sachets. Consider diversifying into personalized medicine platforms like Ways2Well or companies specializing in Liposomal delivery technology, as the market moves toward blood-test-verified, custom-compounded nutrition. In the technology space, the rapid adoption of Perplexity AI for real-time fact-checking suggests a significant shift in search behavior that may disrupt traditional SEO-heavy platforms. For long-term high-reward plays, monitor the emerging Longevity Economy, specifically firms focused on senolytics and cellular age reversal.